Changing the structure of PFOA and PFOS: a chemical industry strategy or a solution to avoid thyroid-disrupting effects?
Authors:
Open Access
- 24 March 2024
- journal article
- review article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 47 (8) , 1863-1879
Abstract
Background: The family of perfluoroalkyl and polyfluoroalkyl substances (PFAS) raised concern for their proven bioaccumulation and persistence in the environment and animals as well as for their hazardous health effects. As a result, new congeners of PFAS have rapidly replaced the so-called “old long-chain PFAS” (mainly PFOA and PFOS), currently out-of-law and banned by most countries. These compounds derive from the original structure of “old long-chain PFAS”, by cutting or making little conformational changes to their structure, thus obtaining new molecules with similar industrial applications. The new congeners were designed to obtain "safer" compounds. Indeed, old-long-chain PFAS were reported to exert thyroid disruptive effects in vitro, and in vivo in animals and humans. However, shreds of evidence accumulated so far indicate that the “restyling” of the old PFAS leads to the production of compounds, not only functionally similar to the previous ones but also potentially not free of adverse health effects and bioaccumulation. Studies aimed at characterizing the effects of new-PFAS congeners on thyroid function indicate that some of these new-PFAS congeners showed similar effects. Purpose: The present review is aimed at providing an overview of recent data regarding the effects of novel PFAS alternatives on thyroid function. Results and conclusions: An extensive review of current legislation and of the shreds of evidence obtained from in vitro and in vivo studies evaluating the effects of the exposure to novel PFOA and PFOS alternatives, as well as of PFAS mixture on thyroid function will be provided.Keywords
Funding Information
- PNRR
- Università degli Studi di Pavia
This publication has 102 references indexed in Scilit:
- Prediagnostic serum concentrations of per‐ and polyfluoroalkyl substances and risk of papillary thyroid cancer in the Finnish Maternity CohortInternational Journal of Cancer, 2023
- HyperthyroidismJAMA, 2023
- A Critical Review of Amphibian Per- and Polyfluoroalkyl Substance Ecotoxicity Research Studies: Identification of Screening Levels in Water and Other Useful Resources for Site-Specific Ecological Risk AssessmentsEnvironmental Toxicology and Chemistry, 2023
- PFOA, PFHxA and C6O4 differently modulate the expression of CXCL8 in normal thyroid cells and in thyroid cancer cell linesEnvironmental Science and Pollution Research, 2023
- In silico analysis decodes transthyretin (TTR) binding and thyroid disrupting effects of per- and polyfluoroalkyl substances (PFAS)Archives of Toxicology, 2022
- Endocrine disrupting chemicals: effects on pituitary, thyroid and adrenal glandsEndocrine, 2022
- Comparative Toxicity of Aquatic Per- and Polyfluoroalkyl Substance Exposure in Three Species of AmphibiansEnvironmental Toxicology and Chemistry, 2022
- Strategic resources for assessing PFAS ecological risks at AFFF sitesIntegrated Environmental Assessment and Management, 2021
- Hypothalamus‐Pituitary‐Thyroid Axis2016
- Determination of polyfluoroalkyl phosphoric acid diesters, perfluoroalkyl phosphonic acids, perfluoroalkyl phosphinic acids, perfluoroalkyl carboxylic acids, and perfluoroalkane sulfonic acids in lake trout from the Great Lakes regionAnalytical and Bioanalytical Chemistry, 2012